Conclusion
Advancements on all levels of proteomics make it possible to integrate
proteomics into clinical applications and thereby complement the missing
piece of the actual phenotype in molecular diagnostics. Integrating
proteomics into the MTB can aid in tumor stratification and the
identification of personalized therapeutic strategies.
We emphasize the merits of data integration which enables more detailed
stratification, classification, and diagnosis based on multiple layers
of molecular information. Data integration promotes a more precise and
comprehensive understanding of the underlying molecular pathomechanisms
and potential therapeutic targets for complex tumor cases.
The frequent discussions within the MTB further promote this integrative
approach and drive both research advancements and clinical applications
paving the way toward precision medicine.